Alfuzosin is not associated with dermatomyositis.
F J
FJ
Navarro-Blasco
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D002277:Carcinoma / Q000150:complications*; D003882:Dermatomyositis / Q000209:etiology*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D011799:Quinazolines / Q000009:adverse effects*; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C047638:alfuzosin